Predictors of New-Onset Heart Failure

DOI Web Site 被引用文献18件
  • Jennifer E. Ho
    From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA (J.E.H., A.L., R.S.V., W.B.K., M.G.L., D.L.); Center for Population Studies, National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.H., D.L.); Cardiovascular Medicine Section, Department of Medicine, Boston University Medical Center, Boston, MA (J.E.H.); Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.); Institute for Clinical Evaluative Sciences, Toronto, Ontario,...
  • Asya Lyass
    From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA (J.E.H., A.L., R.S.V., W.B.K., M.G.L., D.L.); Center for Population Studies, National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.H., D.L.); Cardiovascular Medicine Section, Department of Medicine, Boston University Medical Center, Boston, MA (J.E.H.); Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.); Institute for Clinical Evaluative Sciences, Toronto, Ontario,...
  • Douglas S. Lee
    From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA (J.E.H., A.L., R.S.V., W.B.K., M.G.L., D.L.); Center for Population Studies, National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.H., D.L.); Cardiovascular Medicine Section, Department of Medicine, Boston University Medical Center, Boston, MA (J.E.H.); Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.); Institute for Clinical Evaluative Sciences, Toronto, Ontario,...
  • Ramachandran S. Vasan
    From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA (J.E.H., A.L., R.S.V., W.B.K., M.G.L., D.L.); Center for Population Studies, National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.H., D.L.); Cardiovascular Medicine Section, Department of Medicine, Boston University Medical Center, Boston, MA (J.E.H.); Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.); Institute for Clinical Evaluative Sciences, Toronto, Ontario,...
  • William B. Kannel
    From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA (J.E.H., A.L., R.S.V., W.B.K., M.G.L., D.L.); Center for Population Studies, National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.H., D.L.); Cardiovascular Medicine Section, Department of Medicine, Boston University Medical Center, Boston, MA (J.E.H.); Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.); Institute for Clinical Evaluative Sciences, Toronto, Ontario,...
  • Martin G. Larson
    From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA (J.E.H., A.L., R.S.V., W.B.K., M.G.L., D.L.); Center for Population Studies, National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.H., D.L.); Cardiovascular Medicine Section, Department of Medicine, Boston University Medical Center, Boston, MA (J.E.H.); Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.); Institute for Clinical Evaluative Sciences, Toronto, Ontario,...
  • Daniel Levy
    From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA (J.E.H., A.L., R.S.V., W.B.K., M.G.L., D.L.); Center for Population Studies, National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.H., D.L.); Cardiovascular Medicine Section, Department of Medicine, Boston University Medical Center, Boston, MA (J.E.H.); Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.); Institute for Clinical Evaluative Sciences, Toronto, Ontario,...

書誌事項

タイトル別名
  • Differences in Preserved Versus Reduced Ejection Fraction

説明

<jats:sec> <jats:title>Background—</jats:title> <jats:p>About one half of patients with heart failure (HF) have preserved ejection fraction (HFPEF) rather than reduced ejection fraction (HFREF). The differences in risk factors predisposing to the 2 subtypes of HF are poorly understood. We sought to identify clinical predictors of new-onset HF and to explore differences in HFPEF versus HFREF.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and Results—</jats:title> <jats:p> We studied new-onset HF cases between 1981 and 2008 in Framingham Heart Study participants, classified into HFPEF and HFREF (ejection fraction >45% versus ≤45%). We used Cox multivariable regression to examine predictors of 8-year risk of incident HF and competing-risks analysis to identify predictors that differed between HFPEF and HFREF. Among 6340 participants (60±12 years) with 97 808 person-years of follow-up, 512 developed incident HF. Of 457 participants with left ventricular ejection fraction evaluation at the time of HF diagnosis, 196 (43%) were classified as HFPEF and 261 (56%) as HFREF. Fourteen predictors of overall HF were identified. Older age, diabetes mellitus, and a history of valvular disease predicted both types of HF ( <jats:italic>P</jats:italic> ≤0.0025 for all). Higher body mass index, smoking, and atrial fibrillation predicted HFPEF only, whereas male sex, higher total cholesterol, higher heart rate, hypertension, cardiovascular disease, left ventricular hypertrophy, and left bundle-branch block predicted risk of HFREF. </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>Although multiple risk factors preceded overall HF, distinct clusters of risk factors determine risk for new-onset HFPEF versus HFREF. This knowledge may enable the design of clinical trials of targeted prevention and the introduction of therapeutic strategies for prevention of HF and its 2 major subtypes.</jats:p> </jats:sec>

収録刊行物

被引用文献 (18)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ